Literature DB >> 23275610

Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.

David P Sonne1, Kristine J Hare, Pernille Martens, Jens F Rehfeld, Jens J Holst, Tina Vilsbøll, Filip K Knop.   

Abstract

Preclinical studies suggest that gallbladder emptying, via bile acid-induced activation of the G protein-coupled receptor TGR5 in intestinal L cells, may play a significant role in the secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) and, hence, postprandial glucose homeostasis. We examined the secretion of gut hormones in cholecystectomized subjects to test the hypothesis that gallbladder emptying potentiates postprandial release of GLP-1. Ten cholecystectomized subjects and 10 healthy, age-, gender-, and body mass index-matched control subjects received a standardized fat-rich liquid meal (2,200 kJ). Basal and postprandial plasma concentrations of glucose, insulin, C-peptide, glucagon, GLP-1, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-2 (GLP-2), cholecystokinin (CCK), and gastrin were measured. Furthermore, gastric emptying and duodenal and serum bile acids were measured. We found similar basal glucose concentrations in the two groups, whereas cholecystectomized subjects had elevated postprandial glucose excursions. Cholecystectomized subjects had reduced postprandial concentrations of duodenal bile acids, but preserved postprandial plasma GLP-1 responses, compared with control subjects. Also, cholecystectomized patients exhibited augmented fasting glucagon. Basal plasma CCK concentrations were lower and peak concentrations were higher in cholecystectomized patients. The concentrations of GIP, GLP-2, and gastrin were similar in the two groups. In conclusion, cholecystectomized subjects had preserved postprandial GLP-1 responses in spite of decreased duodenal bile delivery, suggesting that gallbladder emptying is not a prerequisite for GLP-1 release. Cholecystectomized patients demonstrated a slight deterioration of postprandial glycemic control, probably because of metabolic changes unrelated to incretin secretion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23275610     DOI: 10.1152/ajpgi.00435.2012

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  19 in total

Review 1.  Cholecystectomy and the risk of alimentary tract cancers: a systematic review.

Authors:  Maria Coats; Sami M Shimi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 2.  Cholecystectomy and risk of metabolic syndrome.

Authors:  Agostino Di Ciaula; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Eur J Intern Med       Date:  2018-04-26       Impact factor: 4.487

3.  Gallstones, cholecystectomy, and risk of digestive system cancers.

Authors:  Leticia Nogueira; Neal D Freedman; Eric A Engels; Joan L Warren; Felipe Castro; Jill Koshiol
Journal:  Am J Epidemiol       Date:  2014-01-26       Impact factor: 4.897

4.  Bilio-enteric flow and plasma concentrations of bile acids after gastric bypass and sleeve gastrectomy.

Authors:  Aleksander Eiken; Stefan Fuglsang; Markus Eiken; Maria S Svane; Rune E Kuhre; Nicolai J Wewer Albrechtsen; Svend H Hansen; Samuel A J Trammell; Jens S Svenningsen; Jens F Rehfeld; Kirstine N Bojsen-Møller; Nils B Jørgensen; Jens J Holst; Sten Madsbad; Jan L Madsen; Carsten Dirksen
Journal:  Int J Obes (Lond)       Date:  2020-04-21       Impact factor: 5.095

5.  Association of cholecystectomy with metabolic syndrome in a Chinese population.

Authors:  Chao Shen; Xiaoliang Wu; Chengfu Xu; Chaohui Yu; Peng Chen; Youming Li
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

6.  On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes.

Authors:  David P Sonne; Asger Lund; Jens Faber; Jens J Holst; Tina Vilsbøll; Filip K Knop
Journal:  Endocr Connect       Date:  2014-10-02       Impact factor: 3.335

7.  Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake.

Authors:  B Guiastrennec; D P Sonne; M Hansen; J I Bagger; A Lund; J F Rehfeld; O Alskär; M O Karlsson; T Vilsbøll; F K Knop; M Bergstrand
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-12

8.  Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study.

Authors:  Víctor Cortés; Nicolás Quezada; Sergio Uribe; Marco Arrese; Flavio Nervi
Journal:  Lipids Health Dis       Date:  2017-06-30       Impact factor: 3.876

Review 9.  Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation.

Authors:  Li Qi; Wanlin Dai; Jing Kong; Yu Tian; Yongsheng Chen
Journal:  J Physiol Biochem       Date:  2021-07-24       Impact factor: 4.158

10.  The Association Between Cholecystectomy and the Risk for Fracture: A Nationwide Population-Based Cohort Study in Korea.

Authors:  Eun Ji Lee; Cheol Min Shin; Dong Ho Lee; Kyungdo Han; Sang Hyun Park; Yoo Jin Kim; Hyuk Yoon; Young Soo Park; Nayoung Kim
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-27       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.